Michael A. Beazely

2.5k total citations · 1 hit paper
58 papers, 2.0k citations indexed

About

Michael A. Beazely is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael A. Beazely has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael A. Beazely's work include Opioid Use Disorder Treatment (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (13 papers). Michael A. Beazely is often cited by papers focused on Opioid Use Disorder Treatment (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (13 papers). Michael A. Beazely collaborates with scholars based in Canada, United States and Australia. Michael A. Beazely's co-authors include John F. MacDonald, J.R. Dimmock, Michael Jackson, Val J. Watts, Maryam Vasefi, Ravi L. Rungta, Roger Thompson, Brian A. MacVicar, Dustin J. Hines and Michelle E. Olah and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Michael A. Beazely

52 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioactivities of Chalcones

1999 519 citations J.R. Dimmock, Michael A. Beazely et al. Current Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Beazely Canada	22	949	644	501	252	238	58	2.0k
Newton G. Castro Brazil	25	1.4k 1.5×	753 1.2×	371 0.7×	534 2.1×	208 0.9×	47	2.4k
Masamichí Okada Japan	30	1.2k 1.2×	1.3k 2.0×	220 0.4×	188 0.7×	335 1.4×	84	2.7k
Grazia Lombardi Italy	29	1.1k 1.2×	792 1.2×	212 0.4×	134 0.5×	216 0.9×	66	2.3k
Barbara Costa Italy	31	1.2k 1.3×	565 0.9×	586 1.2×	100 0.4×	197 0.8×	111	2.7k
Catia Lambertucci Italy	29	1.5k 1.6×	397 0.6×	761 1.5×	483 1.9×	261 1.1×	113	3.0k
Diego Dal Ben Italy	28	1.6k 1.6×	335 0.5×	683 1.4×	468 1.9×	325 1.4×	98	3.5k
Bassem Sadek United Arab Emirates	30	1.1k 1.2×	393 0.6×	203 0.4×	329 1.3×	172 0.7×	94	2.4k
Feyza Arıcıoğlu Türkiye	24	629 0.7×	650 1.0×	215 0.4×	184 0.7×	268 1.1×	111	1.7k
Mercedes Delgado Spain	23	886 0.9×	386 0.6×	581 1.2×	238 0.9×	196 0.8×	65	2.1k
Gianfranco Balboni Italy	35	2.2k 2.3×	1.6k 2.6×	781 1.6×	271 1.1×	565 2.4×	163	3.6k

Countries citing papers authored by Michael A. Beazely

Since Specialization

Citations

This map shows the geographic impact of Michael A. Beazely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Beazely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Beazely more than expected).

Fields of papers citing papers by Michael A. Beazely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Beazely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Beazely. The network helps show where Michael A. Beazely may publish in the future.

Co-authorship network of co-authors of Michael A. Beazely

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Beazely. A scholar is included among the top collaborators of Michael A. Beazely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Beazely. Michael A. Beazely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shakeri, Arash, et al.. (2025). Novel Phenoselenazines as Amyloid-β Aggregation Inhibitors. ACS Medicinal Chemistry Letters. 16(4). 567–574. 2 indexed citations

Beazely, Michael A., et al.. (2024). Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma. SHILAP Revista de lepidopterología. 12(4). 105–105.

Wong, William, et al.. (2024). An economic evaluation of community pharmacy–dispensed naloxone in Canada. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(2). 84–94.

Rao, Praveen P. N., et al.. (2023). Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity. International Journal of Molecular Sciences. 24(2). 911–911. 9 indexed citations

Beazely, Michael A., et al.. (2022). Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial. SHILAP Revista de lepidopterología. 10(1). 24–24. 1 indexed citations

Daskalakis, George, et al.. (2021). Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another. SHILAP Revista de lepidopterología. 9(3). 129–129. 4 indexed citations

Daskalakis, George, et al.. (2021). What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review. SHILAP Revista de lepidopterología. 9(1). 30–30. 27 indexed citations

Grindrod, Kelly, et al.. (2021). Frequently asked questions about naloxone: Part 1. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 154(5). 301–304. 1 indexed citations

Beazely, Michael A., et al.. (2021). Assessing the impact of a cannabis course on pharmacy students’ understanding, beliefs and preparedness regarding medical and recreational cannabis. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 155(1). 50–59. 2 indexed citations

10.

Robinson, Morgan, et al.. (2021). Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies. International Journal of Molecular Sciences. 22(3). 1051–1051. 13 indexed citations

11.

Grindrod, Kelly, et al.. (2021). Frequently asked questions about naloxone: Part 3. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 155(1). 9–11. 1 indexed citations

12.

Sanyal, Chiranjeev, Caitlin Carter, Beth Sproule, et al.. (2020). The role of pharmacists in opioid stewardship: Protocol. Research in Social and Administrative Pharmacy. 17(5). 993–996. 4 indexed citations

13.

Lai, Dulcie, et al.. (2019). The effects of heat and freeze-thaw cycling on naloxone stability. Harm Reduction Journal. 16(1). 17–17. 8 indexed citations

14.

Vasefi, Maryam, et al.. (2015). Fluoxetine-induced transactivation of the platelet-derived growth factor type β receptor reveals a novel heterologous desensitization process. Molecular and Cellular Neuroscience. 65. 45–51. 6 indexed citations

15.

Vasefi, Maryam, et al.. (2013). Reactive Oxygen Species Are Required for 5-HT-Induced Transactivation of Neuronal Platelet-Derived Growth Factor and TrkB Receptors, but Not for ERK1/2 Activation. PLoS ONE. 8(9). e77027–e77027. 21 indexed citations

16.

Bartos, Jason A., Jason D. Ulrich, Hongbin Li, et al.. (2010). Postsynaptic Clustering and Activation of Pyk2 by PSD-95. Journal of Neuroscience. 30(2). 449–463. 63 indexed citations

17.

Thompson, Roger, Michael Jackson, Michelle E. Olah, et al.. (2008). Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus. Science. 322(5907). 1555–1559. 292 indexed citations

18.

MacDonald, John F., Michael Jackson, & Michael A. Beazely. (2006). G protein-coupled receptors control NMDARs and metaplasticity in the hippocampus. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(4). 941–951. 64 indexed citations

19.

Johnston, Christopher A., et al.. (2002). Heterologous sensitization of adenylate cyclase is protein kinase A‐dependent in Cath.a differentiated (CAD)‐D_2L cells. Journal of Neurochemistry. 82(5). 1087–1096. 17 indexed citations

20.

Dimmock, J.R., et al.. (1999). Bioactivities of Chalcones. Current Medicinal Chemistry. 6(12). 1125–1149. 519 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact